Epidemiology & Genomics Research Program

Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.

Funding Opportunities

Modular R01s in Cancer Control and Population Sciences

PAR-21-190 (R01, Clinical Trial Optional)
Expires March 8, 2024

Assay Validation of High Quality Markers for Clinical Studies in Cancer

PAR-20-313 (UH2/UH3, Clinical Trial Not Allowed) and PAR-20-314 (UH3, Clinical Trials Not Allowed)
Expires October 11, 2023

Co-infection and Cancer

PAR-20-061 (R21 Clinical Trial Not Allowed) and PAR-20-062 (R01 Clinical Trial Not Allowed)
Expires January 8, 2023

Core Infrastructure Support for Cancer Epidemiology Cohorts

PAR-20-294 (U01 - Clinical Trial Not Allowed)
Expires November 10, 2022

Notice of Special Interest: Research in the Emergency Setting

NOT-NS-20-005
Expires September 8, 2022

Genomic Expert Curation Panels

PAR-20-101 (U24 - Clinical Trial Not Allowed)
Expires May 27, 2022

Diet and Physical Activity Assessment Methodology

PA-18-856 (R01 - Clinical Trial Not Allowed) and PAR-18-857 (R21 - Clinical Trial Not Allowed)
Expires September 8, 2021

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors

RFA-CA-20-027 (R01 - Clinical Trial Optional) and RFA-CA-20-028 (R21 - Clinical Trial Optional)
Expires July 31, 2021

Notice of Special Interest: Administrative Supplement for Genome-wide Genotyping of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data

NOT-CA-21-049
Expires May 21, 2021

Find More Opportunities

Featured Resource

Human Health Exposure Analysis Resource

NCI-funded investigators may apply to use the HHEAR to integrate environmental exposures into existing studies. Applications accepted until May 14, 2021.

Learn MoreExternal Web Site Policy

Meet Our Associate Director

An Interview with Kathy J. Helzlsouer, M.D., M.H.S.

Dr. Helzlsouer speaks about her background in oncology and epidemiology, the people and experiences that drive her passion for cancer research, and her ideas about future directions for EGRP.

Watch the InterviewExternal Web Site Policy

What's New

New Guidance Documents for Researchers Conducting Studies on Immune Response to COVID-19 Vaccines

Investigators involved with NCI's Serological Sciences Network (SeroNet) have created guidance documents for researchers conducting studies on the immune response to vaccines to encourage harmonization across studies and to allow for cross-study comparisons.

Request for Information

NCI is seeking information on opportunities to leverage populations participating in NCI’s National Clinical Trial Network (NCTN) and Community Oncology Research Program (NCORP) for observational cohort studies to fill evidence gaps in cancer survivorship knowledge. Responses are requested by May 3, 2021. View details in the NIH Guide, NOT-CA-21-036.

Physical Activity Assessment Resources

Check out our compilation of research resources related to physical activity, including analytical & assessment tools and datasets, including recently released National Health and Nutrition Examination Survey (NHANES) Physical Activity Monitor Data.

Information on Notices of Special Interest (NOSIs) and How They Work

A NOSI describes aims in a specific scientific area and points to one or more funding opportunity announcements that investigators can apply to for support. Visit our overview of NOSIs for additional details.

Considerations when Developing a Data Sharing Plan

Tips for investigators on preparing data sharing plans that comply with NIH's data sharing policies.

Connect With Us

Subscribe for Updates

Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.

Subscribe to the E-Newsletter

Need Help?

EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.

Email Us
(240) 276-6730
Last Updated: 07 Apr, 2021